Structure-antibacterial activity relationships of anacardic acids

Anacardic acid derivatives from Brazilian propolis and their antibacterial activity

“…The biological activities of the anacardic acid derivatives have attracted considerable attention for acting as molluscicides [26], anti-tumour agents [27][28], antimicrobes [29][30][31][32], antioxidants [33] and xanthine oxidase inhibitiors [34].…”

“…Although the Anacardium extracts are reported to be antitumour agents [27,28,30,31] and non-carcinogenic, the Ginkgo extracts are reported to be cytotoxic agents [35,36,37]. However, it should be noted that there is no solid proof of a strong allergic reaction to these alkyl-phenols when taken orally [38].…”

Invited review: Large-scale indirect measurements for enteric methane emissions in dairy cattle: A review of proxies and their potential for use in management and breeding decisions

“…For instance, inhibitors of the enzyme methyl coenzyme-M reductase (which is involved in the last step of the methanogenic pathway), such as bromochoromethane (Denman et al, 2007), chloroform (Knight et al, 2011), or 3-nitrooxypropanol (Haisan et al, 2014), did not always result in a reduction of methanogen numbers (Romero-Perez et al, 2014. Other compounds known for their antimicrobial activities were also shown to induce reductions in both MeP and methanogen numbers (Kubo et al, 1993;Iwamoto et al, 2002). Examples of these are nitrates (van Zijderveld et al, 2010;Veneman et al, 2015), anacardic acid contained in cashew nut shell liquid (Shinkai et al, 2012), monensin (Shinkai et al, 2012), and isobutyrate (Wang et al, 2015).…”

A review on scientific technologies in practice to innovate plant based molecules and to improve herbal drug quality to overcome health problems

“…Several researchers have worked on medicinal plants with activity against different ailments. In recent years, the scientific evidence on the effectiveness of herbal drugs has become the focus of intense study in terms of their antimicrobial activity against certain microbial model in order to prove their efficacy (Amagboul et al, 1985;Artizzu et al, 1995;Izzo et al, 1995;Kubo et al, 1993;Sousa et al, 1991;Shapoval et al, 1994;Kandhansamy and Anurachalam, 2008;AlBayati, 2008;Czech et al, 2000). The emergence of MDR strains has made it difficult for clinicians to empirically select an appropriate antimicrobial agent (Walker, 2000).…”